Skip to main content
. 2020 Nov 6;12:11371–11382. doi: 10.2147/CMAR.S274058

Figure 4.

Figure 4

P-MAPK14 maintains the stability of the RUNX2 protein (A) Cells stably knockdown of MAPK14 (shMAPK14) and control group (Vector) were treated with DMSO or MG-132, followed by Western blot assay; (B) Cells stably knockdown of MAPK14 (shMAPK14) and control group (Vector) were treated with 100 μg/mL cycloheximide for the indicate times. Total cellular lysates were subjected to Western blot assay. (*P < 0.05, **P < 0.01).